AgomAb Therapeutics N.V. American Depositary Shares
NASDAQ:AGMBBiotechnology
+$0.25 today
- Market cap
- $286.62M
- Beta
- 2.62
- P/E (TTM)
- -7.1
- EPS (TTM)
- -$1.28
Volume 0.13M
Average 0.14M
AGMB Cash & Equivalents
Cash on hand and highly liquid investments that can be converted to cash almost immediately.
AgomAb Therapeutics N.V. American Depositary SharesNASDAQ: AGMB
Cash & Equivalents · Q3 FY2025 · quarter ended Sep 2025
Cash & equivalents of €129.59M in Q3 FY2025
Q3 FY2025 cash & equivalents was €129.59M.
Context
- Cash & equivalents amounted to 78.2% of total assets at the end of Q3 FY2025.
Sources:Balance SheetText generated from reported figures; not investment advice.
Cash & Equivalents history
Currency unavailable · from the balance sheet
No Cash & Equivalents data reported for this period type.
Cash & Equivalents vs competitors
How AGMB compares with its peers on the latest reported figures
- Peers report in different currencies, so cash & equivalents is compared through growth and share of total assets rather than absolute size.
- Cash & equivalents amounts to 78.2% of total assets for AGMB, versus a peer median of 44.9%.
| Company | Period | Latest balance | YoY | 3-year CAGR | % of assets |
|---|---|---|---|---|---|
| Mar 2026 | $248.47M USD | +151.9% | +49.5% | 75.4% | |
AGMBAgomAb Therapeutics N.V. American Depositary Shares | Sep 2025 | €129.59M EUR | — | — | 78.2% |
ALMSAlumis Inc. Common Stock | Jun 2026 | $63.71M USD | -58.0% | +51.8% | 11.4% |
| Mar 2026 | $61.32M USD | +322.9% | -20.0% | 97.2% | |
| Mar 2026 | $28.66M USD | -5.6% | -23.9% | 14.4% | |
ODTXOdyssey Therapeutics, Inc. | — | — | — | — | — |
| Peer median (excluding AGMB) | — | +73.2% | +14.7% | 44.9% | |
Competitors are the stored peer set for AGMB. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Balance Sheet
AgomAb Therapeutics N.V. American Depositary Shares
NASDAQ:AGMB
Intrinsic Alpha fair value
Locked
Current Price
$5.82
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.